Annual Cash & Cash Equivalents
$26.67 M
-$2.98 M-10.05%
December 31, 2023
Summary
- As of February 7, 2025, CLGN annual cash & cash equivalents is $26.67 million, with the most recent change of -$2.98 million (-10.05%) on December 31, 2023.
- During the last 3 years, CLGN annual cash & cash equivalents has risen by +$23.34 million (+700.30%).
- CLGN annual cash & cash equivalents is now -10.05% below its all-time high of $29.65 million, reached on December 31, 2022.
Performance
CLGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.37 M
-$3.55 M-18.76%
September 30, 2024
Summary
- As of February 7, 2025, CLGN quarterly cash and cash equivalents is $15.37 million, with the most recent change of -$3.55 million (-18.76%) on September 30, 2024.
- Over the past year, CLGN quarterly cash and cash equivalents has dropped by -$13.61 million (-46.96%).
- CLGN quarterly cash and cash equivalents is now -62.58% below its all-time high of $41.07 million, reached on March 31, 2022.
Performance
CLGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLGN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.1% | -47.0% |
| 3 y3 years | +700.3% | -47.0% |
| 5 y5 years | +398.2% | -47.0% |
CLGN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.1% | +102.9% | -62.6% | +16.9% |
| 5 y | 5-year | -10.1% | +700.3% | -62.6% | +361.2% |
| alltime | all time | -10.1% | +2602.3% | -62.6% | +4212.9% |
CollPlant Biotechnologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.37 M(-18.8%) |
| Jun 2024 | - | $18.92 M(-18.5%) |
| Mar 2024 | - | $23.23 M(-12.9%) |
| Dec 2023 | $26.67 M(-10.0%) | $26.67 M(-8.0%) |
| Sep 2023 | - | $28.98 M(+30.1%) |
| Jun 2023 | - | $22.28 M(-16.0%) |
| Mar 2023 | - | $26.53 M(-10.5%) |
| Dec 2022 | $29.65 M(+125.5%) | $29.65 M(-9.6%) |
| Sep 2022 | - | $32.81 M(-9.6%) |
| Jun 2022 | - | $36.29 M(-11.6%) |
| Mar 2022 | - | $41.07 M(+212.4%) |
| Dec 2021 | $13.15 M(+294.5%) | - |
| Dec 2021 | - | $13.15 M(-48.9%) |
| Sep 2021 | - | $25.75 M(+47.3%) |
| Jun 2021 | - | $17.48 M(-11.4%) |
| Mar 2021 | - | $19.72 M(+491.8%) |
| Dec 2020 | $3.33 M(-12.1%) | - |
| Dec 2020 | - | $3.33 M(-33.8%) |
| Sep 2020 | - | $5.04 M(+37.1%) |
| Jun 2020 | - | $3.67 M(-34.6%) |
| Mar 2020 | - | $5.61 M(+48.1%) |
| Dec 2019 | $3.79 M | - |
| Dec 2019 | - | $3.79 M(-34.0%) |
| Sep 2019 | - | $5.74 M(+229.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $1.74 M(-53.1%) |
| Mar 2019 | - | $3.71 M(-30.7%) |
| Dec 2018 | $5.35 M(+4.4%) | - |
| Dec 2018 | - | $5.35 M(+104.9%) |
| Sep 2018 | - | $2.61 M(+2.1%) |
| Jun 2018 | - | $2.56 M(-35.1%) |
| Mar 2018 | - | $3.94 M(-23.1%) |
| Dec 2017 | $5.13 M(+419.3%) | - |
| Dec 2017 | - | $5.13 M(+120.3%) |
| Sep 2017 | - | $2.33 M(+78.7%) |
| Jun 2017 | - | $1.30 M(+6.3%) |
| Mar 2017 | - | $1.22 M(+24.0%) |
| Dec 2016 | $987.10 K(-27.5%) | - |
| Dec 2016 | - | $987.10 K(-53.5%) |
| Sep 2016 | - | $2.12 M(-26.4%) |
| Jun 2016 | - | $2.88 M(+90.0%) |
| Mar 2016 | - | $1.52 M(+11.4%) |
| Dec 2015 | $1.36 M(-52.1%) | - |
| Dec 2015 | - | $1.36 M(-38.5%) |
| Sep 2015 | - | $2.21 M(+521.3%) |
| Jun 2015 | - | $356.40 K(-87.5%) |
| Dec 2014 | $2.84 M(-58.4%) | - |
| Dec 2014 | - | $2.84 M |
| Dec 2013 | $6.83 M | - |
FAQ
- What is CollPlant Biotechnologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies annual cash & cash equivalents year-on-year change?
- What is CollPlant Biotechnologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies quarterly cash and cash equivalents year-on-year change?
What is CollPlant Biotechnologies annual cash & cash equivalents?
The current annual cash & cash equivalents of CLGN is $26.67 M
What is the all time high annual cash & cash equivalents for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high annual cash & cash equivalents is $29.65 M
What is CollPlant Biotechnologies annual cash & cash equivalents year-on-year change?
Over the past year, CLGN annual cash & cash equivalents has changed by -$2.98 M (-10.05%)
What is CollPlant Biotechnologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLGN is $15.37 M
What is the all time high quarterly cash and cash equivalents for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high quarterly cash and cash equivalents is $41.07 M
What is CollPlant Biotechnologies quarterly cash and cash equivalents year-on-year change?
Over the past year, CLGN quarterly cash and cash equivalents has changed by -$13.61 M (-46.96%)